Treatments
553 articles
Comparing Treatment Delivery Methods for Locally Advanced Pancreatic Cancer
A clinical trial compares intravenous chemotherapy delivery with intra-arterial chemotherapy to see which is more effective for pancreatic cancer.
Immunotherapy Combination Plus Radiation for Pancreatic Cancer
Researchers are testing two monoclonal antibodies approved to treat melanoma plus radiation as a treatment for pancreatic cancer.
Testing an Experimental Combination of Drugs
A clinical trial for some cancers including pancreatic cancer tests the effectiveness of a checkpoint inhibitor and an antisense oligonucleotide inhibitor.
Study Finds Rare Immunotherapy Exceptional Responders
Immunotherapy is not very effective against pancreatic cancer, but Dr. Jordan Winter is taking a closer look at patients who benefitted to see what’s different about them.
Patient-Focused Research to Better Understand Pancreatic Cancer
Dr. Diane Simeone stresses the importance of research and clinical trials to get better results for pancreatic cancer patients.
Finding the Best Diabetes Drug for Pancreatic Cancer Patients
With all the various drugs out there, Dr. James Flory wants to establish which diabetes drug works best for pancreatic cancer patients. Read his expert advice.
Lustgarten–AACR Name Career Development Award Winners
The Lustgarten Foundation and AACR announced the winners of the 2022 Ruth Bader Ginsburg and John Robert Lewis Career Development Awards.
Standard of Care Plus
Dr. Allyson Ocean explains why pancreatic cancer patients should consider clinical trials, which go beyond standard of care.
Cracking the KRAS Code
Dr. Despina Siolas is focusing her research on new treatments for pancreatic cancer, particularly ones that go after KRAS mutations.
An Update on Vitamin C and Cancer
Vitamin C can have a positive impact on pancreatic cancer treatments. Read the latest research on vitamin C’s role in the fight against pancreatic cancer.
Two-Drug Combo Targets KRAS and Fights Resistance
Researcher Hervé Tiriac leads a clinical trial for a new drug combination targeting KRAS and chemotherapy resistance.
Chemotherapy Regimen for Post-Surgery PNET Patients
Will a chemotherapy combination be effective against PNET after high-grade tumors are surgically removed? A clinical trial takes a closer look.
AI Platform Reveals Hidden Biology of Tumor Formation
Dr. Laura Wood and colleagues are developing an artificial intelligence (AI) platform to identify tumors as they are forming.
PanCAN 2021 Annual Scientific Summit
Pancreatic Cancer Action Network (PanCAN) held its annual scientific summit for an overview of the latest research projects they are funding.
Representing Genetic and Clinical Diversity in Pancreatic Cancer
Dr. Kentaro Sudo explores the possible causes for different responses to drugs among ethnic groups, pointing to the need for clinical diversity in trials.